Limin Liu

USPTO Granted Patents = 15 (Patent Applications = 2)

CIPO Patents = 4

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 102(Granted Patents)

Company Filing History:

6 out of 321

General Atomics, Inc.

Societe Des Produits Nestle S.a.

patents

4. 1 out of 22

Prometheus Laboratories Inc.

Years Active: 2010-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11860170 - Assay method for the detection of VCAM-1 and alpha-2-macroglobulin in blood (2024-01-02),

2. 10527622 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2020-01-07),

3. 10436786 - Methods for detecting truncated receptors using antibody-based arrays (2019-10-08),

4. 9575066 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2017-02-21),

5. 9285369 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2016-03-15),

6. 9274116 - Drug selection for breast cancer therapy using antibody-based arrays (2016-03-01),

7. 8673646 - Electrochemical biosensor for direct determination of percentage of glycated hemoglobin (2014-03-18),

8. 8658388 - Antibody-based arrays for detecting multiple signal transducers in rate circulating cells (2014-02-25),

9. 8609349 - Drug selection for breast cancer therapy using antibody-based arrays (2013-12-17),

10. 8557591 - Methods for assaying percentage of glycated hemoglobin (2013-10-15),

11. 8338184 - Methods for assaying percentage of glycated hemoglobin (2012-12-25),

12. 8318501 - Methods for assaying percentage of glycated hemoglobin (2012-11-27),

13. 8163499 - Drug selection for breast cancer therapy using antibody-based arrays (2012-04-24),

14. 7943385 - Methods for assaying percentage of glycated hemoglobin (2011-05-17),

15. 7855079 - Methods for assaying percentage of glycated hemoglobin (2010-12-21),

Title: The Innovative Mind of Limin Liu

Introduction

Limin Liu, based in San Diego, CA, is an accomplished inventor with a remarkable portfolio of 15 patents. His innovations significantly contribute to the fields of biotechnology and medical diagnostics, showcasing his dedication to enhancing healthcare solutions.

Latest Patents

Among Liu's latest patents is an **assay method for the detection of VCAM-1 and alpha-2-macroglobulin in blood**. This method utilizes fluorescence resonance energy transfer (FRET) to detect the presence or amounts of VCAM-1 and A2M in a sample, potentially aiding in various medical diagnoses. Another notable invention is the **antibody-based arrays for detecting multiple signal transducers in rare circulating cells**. This invention provides new tools for assessing the activation state and total amounts of various signal transduction molecules in rare circulating cells, aimed at facilitating cancer prognosis and diagnosis, along with the development of personalized, targeted therapies.

Career Highlights

Limin Liu has had a diverse career, having worked for esteemed companies such as General Atomics, Inc. and Nestec S.A. His experiences in these organizations have undoubtedly enriched his knowledge and expertise, allowing him to drive innovation in his field.

Collaborations

Throughout his professional journey, Liu has collaborated with talented individuals such as Sharat Singh and Jeanne Harvey. These partnerships have contributed to the evolution of his ideas and the successful realization of his inventive concepts.

Conclusion

Limin Liu stands out as a prominent inventor whose work is making significant strides in biotechnology and medical diagnostics. His innovative patents and collaborations illustrate a commitment to enhancing healthcare through technology. With each invention, Liu continues to pave the way for improved diagnostic methods and therapies, marking him as a key figure in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.